eGFR Changes in Uncontrolled Gout Patients Undergoing Pegloticase Plus Methotrexate Co-Therapy

被引:0
|
作者
Marder, Brad A. [1 ]
Albert, John A. [2 ]
Broadwell, Aaron [3 ]
Padnick-Silver, Lissa [1 ]
LaMoreaux, Brian [1 ]
机构
[1] Horizon Therapeut Plc, Deerfield, IL USA
[2] Rheumat Dis Ctr, Milwaukee, WI USA
[3] Rheumatol & Osteoporosis Specialists, Shreveport, LA USA
来源
关键词
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
SA-PO897
引用
收藏
页码:851 / 851
页数:1
相关论文
共 50 条
  • [1] eGFR Changes in Uncontrolled Gout Patients Undergoing Pegloticase plus Methotrexate Co-therapy
    Albert, John
    Broadwell, Aaron
    Padnick-Silver, Lissa
    Marder, Brad
    LaMoreaux, Brian
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 3606 - 3607
  • [2] eGFR Changes in Uncontrolled Gout Patients Randomized to Receive Methotrexate or Placebo as Co-Therapy to Pegloticase: MIRROR RCT Findings
    Abdellatif, Abdul A.
    Botson, John K.
    Obermeyer, Katie L.
    LaMoreaux, Brian
    Marder, Brad A.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 851 - 851
  • [3] LEFLUNOMIDE CO-THERAPY WITH PEGLOTICASE IN UNCONTROLLED GOUT
    Masri, K.
    Winterling, K.
    Lamoreaux, B.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 450 - 450
  • [4] Intensive urate-lowering with pegloticase plus methotrexate co-therapy in uncontrolled gout patients with and without chronic kidney disease: A retrospective case series
    Albert, John
    Broadwell, Aaron
    Padnick-Silver, Lissa
    Marder, Brad
    LaMoreaux, Brian
    MEDICINE, 2024, 103 (10) : E37424
  • [5] PHARMACOKINETICS OF PEGLOTICASE AND METHOTREXATE POLYGLUTAMATE(S) IN PATIENTS WITH UNCONTROLLED GOUT RECEIVING PEGLOTICASE AND CO-TREATMENT OF METHOTREXATE
    Song, Y.
    Xin, Y.
    Weinblatt, M. E.
    Chamberlain, J.
    Obermeyer, K.
    Zhao, L.
    Canavan, C.
    Peloso, P. M.
    Ramanathan, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 847 - 848
  • [6] PHARMACOKINETICS OF PEGLOTICASE AND METHOTREXATE POLYGLUTAMATE(S) IN PATIENTS WITH UNCONTROLLED GOUT RECEIVING PEGLOTICASE AND CO-TREATMENT WITH METHOTREXATE
    Xin, Y.
    Song, Y.
    Weinblatt, M. E.
    Chamberlain, J.
    Zarzoso, J.
    Obermeyer, K.
    Sainati, S.
    Canavan, C.
    Ramanathan, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 910 - 910
  • [7] Pharmacokinetics of Pegloticase and Methotrexate Polyglutamate(s) in Patients with Uncontrolled Gout Receiving Pegloticase and Cotreatment of Methotrexate
    Song, Yang
    Xin, Yan
    Weinblatt, Michael
    Chamberlain, Jason
    Obermeyer, Katie
    Zhao, Lin
    Canavan, Colleen
    Peloso, Paul
    Ramanathan, Srini
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [8] EGFR CHANGES DURING PEGLOTICASE TREATMENT WITH AND WITHOUT METHOTREXATE CO-THERAPY: 12-MONTH FINDINGS OF MIRROR RCT
    Abdellatif, Abdul
    Botson, John
    Obermeyer, Katie
    Padnick-Silver, Lissa
    Marder, Brad
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2023, 81 (04) : S67 - S67
  • [9] REAL-WORLD REPORTING OF GOUT FLARES IN UNCONTROLLED GOUT PATIENTS CO-TREATED WITH PEGLOTICASE AND METHOTREXATE
    Albert, J.
    Padnick-Silver, L.
    Lamoreaux, B.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1644 - 1644
  • [10] Improved joint and patient-reported health assessments with pegloticase plus methotrexate co-therapy in patients with uncontrolled gout: 12-month exploratory outcomes of the MIRROR open-label trial
    John K. Botson
    Katie Obermeyer
    Brian LaMoreaux
    Lin Zhao
    Michael E. Weinblatt
    Jeff Peterson
    Arthritis Research & Therapy, 24